Bleeding risk with rivaroxaban compared with vitamin K antagonists in patients aged 80 years or older with atrial fibrillation
Olivier Hanon, Jean-Sébastien Vidal, George Pisica-Donose, Galdric Orvoën, Jean-Philippe David, Edouard Chaussade, Laure Caillard, Laura W de Jong, Nicolas Boulloche, Ulric Vinsonneau, Stéphane Bouée, Pierre Krolak-Salmon, Laurent Fauchier, Pierre Jouanny, Guillaume Sacco, Fabienne Bellarbre, Joël Belmin, François Puisieux, Matthieu Lilamand, Elena Paillaud, Anne Sophie Boureau
Heart Sep 2021, 107 (17) 1376-1382; DOI: 10.1136/heartjnl-2020-317923